Clinical Study
Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
Table 2
Neoadjuvant and adjuvant treatment modalities.
| Parameter | Group A
| Group B
| value |
| Neoadjuvant hormonal therapy (/%/) | 38 (29.0%) | 33 (44.6%) | 0.025 | Adjuvant radiotherapy (ART) (/%/) | 21 (16.0%) | 27 (36.5%) | 0.001 | Adjuvant hormonal therapy (ADT) (/%/) | 29 (22.1%) | 29 (39.2%) | 0.010 | Adjuvant combined (ART & ADT) therapy (/%/) | 13 (9.9%) | 17 (23.0%) | 0.012 |
|
|